NATUS MEDICAL INC. overview

NATUS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Natus Medical Incorporated To Contact The Firm PR Newswire NEW YORK, Feb. 27, 2019 NEW YORK , Feb. 27, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Natus Medical Incorporated ("Natus" or the "Company") (NASDAQ: BABY). If you invested in Natus stock or options and would like to discuss your legal rights,...

Gibbs Law Group is investigating claims on behalf of investors of Natus Medical Incorporated (NASDAQ: BABY) involving possible securities law violations. Specifically, our investigation focuses on allegations that Natus Medical and certain of its officers and/or directors may have engaged in unlawful business practices or securities fraud. To speak privately with an attorney regarding this class action lawsuit investigation, click here . On February 6, 2019, GlassHouse Research published a...

Zamansky LLC announces that it is investigating Natus Medical Incorporated (NASDAQ: BABY) (“Natus” or the “Company”) for potential breaches of fiduciary duties concerning its accounting practices, specifically with regard to its allegedly obsolete inventory. If you are a Natus shareholder and still hold your BABY shares, please contact our firm for further information. As recently reported, Natus’ accounting practices have been called into question by a third-party short seller. It has...

Holzer & Holzer, LLC is investigating whether certain statements made by Natus Medical, Inc. (“Natus Medical” or the “Company”) (NASDAQ: BABY) complied with federal securities laws. On February 6, 2019, the price of Natus Medical shares fell significantly following a short seller report accusing the Company of deceptive accounting practices. If you purchased Natus Medical shares and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at...

NEW YORK, NY / ACCESSWIRE / February 7, 2018 / Natus Medical Incorporated (NASDAQ: BABY ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 7, 2018 at 11:00 AM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/23506 To receive updates for this company you can register by emailing [email protected] or by clicking get investment info from the company's profile. About Investor...

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Natus Medical Incorporated - BABY PR Newswire NEW YORK, March 24, 2017 NEW YORK , March 24, 2017 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Natus Medical Incorporated securities (NASDAQ: BABY) from October 16, 2015 through April 3, 2016 , inclusive (the "Class Period"). The lawsuit seeks to recover damages for...